Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.56 |
| ▸ | L3MBTL3 | Q96JM7 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.50 |
| ▸ | PHGDH | O43175 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL583879 | 1.00 | HTR6 (0.56) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL21422636 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL60131 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL2107230 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL728754 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL24782761 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL21057384 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL22216666 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL21057351 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL | |
| SCHEMBL1828721 | 0.97 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1PHGDHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4759 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048156-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2026-02-19 | — | — | US | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4486395-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2025-01-08 | — | — | EP | claimed |
| EP-4452326-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2024-10-30 | — | — | EP | claimed |
| CN-118785925-A | Marker precursors and radiotracers with three or more targeting vectors for use in diagnostic nuclear medicine therapies | 原子治疗有限公司 | 2024-10-15 | — | — | CN | claimed |
| WO-2024133900-A1 | IMPROVED (-)-SPARTEINE PRODUCTION | UNIVERSITY OF COPENHAGEN (DK) | 2024-06-27 | — | — | WO | claimed |
| EP-3018723-B1 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-05-08 | — | — | EP | claimed |
| US-20240092815-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | claimed |
| WO-2023241290-A1 | PHARMACEUTICAL COMPOUND BASED ON QUINOLIZIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海工程技术大学 | 2023-12-21 | — | — | WO | claimed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| US-4716172-A | 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates | MCNEILAB, INC. (US) | 1987-12-29 | — | — | US | claimed |
| EP-0241292-A2 | 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates | McNeilab, Inc. (US) | 1987-10-14 | — | — | EP | claimed |
| EP-0240275-A2 | Novel phosphorus-containing coumarins | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-10-07 | — | — | EP | claimed |
| EP-0001290-B1 | SUBSTITUTED 2,3-DIHYDROBENZ-(D)-ISOTHIAZOLE-1,1-DIOXIDES AND 2,3-DIHYDRONAPHTHO-(1,8-DE)-1,2-THIAZINE-1,1-DIOXIDES | POLAROID CORPORATION (US) | 1984-06-27 | — | — | EP | claimed |
| US-4283538-A | LIGHT SCREENING DYES FOR COLOR FILMS | POLAROID CORPORATION (US) | 1981-08-11 | — | — | US | claimed |
| US-4231929-A | Sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-11-04 | — | — | US | claimed |
| EP-0004260-B1 | SUBSTITUTED QUINOLIZIDINE AND INDOLIZIDINE-METHANOL DERIVATIVES, METHOD FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Hokuriku Pharmaceutical Co.,Ltd (JP) | 1980-10-29 | — | — | EP | claimed |
| US-4228075-A | Novel sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-10-14 | — | — | US | claimed |
| US-4205074-A | Anti-spasmodic substituted quinolizidine and indolizidine compounds | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1980-05-27 | — | — | US | claimed |
| WO-1979000319-A1 | NEW INDOLO(2,3-A)QUINOLIZIDINES,PREPARATION AND THERAPEUTIC USE THEREOF | BUZAS ANDRE (FR) | 1979-06-14 | — | — | WO | claimed |